About COVID-19 Convalescent Plasma
COVID-19 Convalescent Plasma
Coronavirus disease 2019 (COVID-19), the disease associated with SARS-CoV2 virus and responsible for a world-wide pandemic, disproportionally affects patients with co-morbid malignancies. In fact, the mortality rate in cancer patients with COVID-19 is 28%, more than double that of age and sex-matched controls. This high mortality rate may be the result of several possibilities including that many patients are immunocompromised due to their malignancy and/or their treatment for those cancers. Another factor is that cancer patients often must visit health care centers, many of which are caring for COVID-19 patients.